Doxorubicin-based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review
Conclusion PBL can be successfully treated with aggressive chemotherapy followed by RT. Treatment was well tolerated and can result in long-term survival for patients with limited-stage disease.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Dexamethasone | Leukemia | Lymphoma | Myeloma | Prednisone | Radiation Therapy | Toxicology